Search

everythinglearnresearchcommunity

for

Search:↓

Collaboration and innovation are key to developing effective, safe hair loss treatments.

The shampoo straightens hair while keeping it healthy and less damaged.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

Microneedling improves skin and hair conditions by enhancing treatment absorption and stimulating growth factors.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Combining minoxidil with MS injections leads to better hair regrowth in men.

Stem cells and biomaterials are key to improving skin substitutes for medical use.

Immunocompromised patients can develop skin and hair issues due to a virus.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

A British Bulldog had a unique viral plaque caused by Canine papillomavirus 18, different from typical tumors.

A doughnut-shaped wart can form after cryotherapy in people with alopecia areata due to immune system issues.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Biomaterials can improve non-viral gene delivery by enhancing DNA uptake and reducing toxicity.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Fad diets and supplements from social media can cause skin and hair problems.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.